Position in HLN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$17,559
+$3,525 QoQ
Shares Held
1,882
+34.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#451
of 640 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026E Fund Management (Hong Kong) Co., Ltd. holds $161,198 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
152 | $25,618 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
46 | $24,924 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
655 | $22,191 | |
| 4 | VTRS |
Viatris Inc
|
1,363 | $21,644 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
1,341 | $19,431 | |
| 6 | HLN |
Haleon plc
This page
|
1,882 | $17,559 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,081 | $17,328 | |
| 8 | ZTS |
Zoetis Inc.
|
174 | $12,503 |
All Filings in HLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,559 | 1,882 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $14,034 | 1,402 | Shares | Sole | 2026-04-08 | |
| No filing history on record for this holder in this stock. | ||||||